Research Roundup ยท 2026

Reference Hub: Prognosis and treatment of Fosamax-related Osteonecrosis of the Jaw

An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.

Recommended deep-dive

Prognosis and treatment of Fosamax-related Osteonecrosis of the Jaw Resource Guide

A focused look at the background, context, and key sources on this subject.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.